Repros Therapeutics shares drop on drug application setback
October 17, 2014 at 09:15 AM EDT
Repros Therapeutics shares tumble in premarket trade after the U.S. FDA said there isn’t enough clinical data to hold a previously-planned pre-investigational new drug application meeting.